Efficacy and safety data from the Effisayil™ 1 trial presented at AAD 2022 showed spesolimab is associated with rapid pustular and skin clearance in patients with a GPP flare, sustained over the...

Company to Showcase Cutting Edge Solutions for Active Copper Interconnects up to 800Gbps SAN JOSE, Calif., March 28, 2022 /PRNewswire/ -- (TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders, today...

UAE welcomes Crypto.com's decision to set up regional base in Dubai and its support for inaugural Investopia conference Crypto.com aims to play a role in furthering global financial innovation...

DALLAS, March 28, 2022 PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing optogenetic gene therapies to treat retinal degenerative diseases, today...

GDT002 shown to have a potent anti-tumor activity across a broad spectrum of solid and liquid tumors Ovarian cancer selected from broad screening of solid tumor types as the indication for GDT002...

The 8th China EV 100 was held in Beijing from March 25th to 27th, with the theme of "Embracing a New Stage of NEV's Market-Driven Growth". In-depth discussions were made on policy adjustment in...

The Internet Corporation for Assigned Names and Numbers (ICANN) kicks off the first Domain Name System (DNS) Forum in Asia Pacific (APAC) this week from 30 March to 1 April 2022. ICANN is an...

Ascletis Pharma Inc. (HKEX:1672) today announces that the latest preclinical research results of the company's two novel anti-cancer drug candidates, ASC61, an oral PD-L1 inhibitor and ASC60, an...

Eleven abstracts highlight new data on bimekizumab in the treatment of adults with moderate to severe plaque psoriasis Pooled data from five Phase 3/3b trials showed that more than eight out of 10...